Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the
Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Takeover/Mergers & Acquisitions
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the
Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
23-May-2024 / 06:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the
Bormioli Pharma Group - Moulded Glass business to be strategically reviewed
Düsseldorf, May 23, 2024. Gerresheimer Glas GmbH, an indirect subsidiary of
Gerresheimer AG, has today signed a purchase agreement with funds advised by
Triton ("Triton") for the acquisition of Blitz LuxCo Sarl, the holding
company of the Bormioli Pharma Group ("Bormioli Pharma"). The purchase price
is based on a determined enterprise value of around EUR 800 million, which
corresponds to an adj. EBITDA multiple of approx. 10. The group of companies
has 9 production sites in Europe.
Bormioli Pharma has a complementary portfolio of pharmaceutical primary
packaging made of glass and plastic, as well as closure solutions,
accessories, and dosing systems. With the acquisition, Gerresheimer is also
strengthening its European presence with additional production sites,
especially in Southern Europe.
With the acquisition, a new Moulded Glass business unit will be created
after the integration, with new options for strategic realignment.
The transaction will be financed by a consortium of banks consisting of
UniCredit, Commerzbank and LBBW.
The transaction is subject to customary closing conditions and approvals.
The transaction is expected to close in Q4 of fiscal 2024.
End of inside information
Gerresheimer will hold a conference call on the transaction on May 23, 2024,
09:00 am CEST. For more information, see
https://www.gerresheimer.com/en/company/investor-relations/presentations
Contact Gerresheimer AG
Guido Pickert
Vice President Investor Relations
T +49 211 6181-220
gerresheimer.ir@gerresheimer.com
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg@gerresheimer.com
End of Inside Information
---------------------------------------------------------------------------
23-May-2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
---------------------------------------------------------------------------
Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard);
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1908113
End of Announcement EQS News Service
---------------------------------------------------------------------------
1908113 23-May-2024 CET/CEST